NSE: NEULANDLAB - Neuland Laboratories Limited

Yield per half year: +112.1%
Sector: Healthcare

Share chart Neuland Laboratories Limited


About

Neuland Laboratories Limited производит и продает активные фармацевтические ингредиенты (АФИ) в Индии, Европе, США и за рубежом. АФИ компании используются в различных терапевтических областях, включая противоастматические, сердечно-сосудистые, противогрибковые, противосудорожные средства, средства для центральной нервной системы, фторхинолоны, антипсихотические, антибактериальные и противопаркинсонические средства. Он также предоставляет индивидуальные производственные решения, а также услуги по синтезу пептидов.

More details
Компания была зарегистрирована в 1984 году, ее штаб-квартира находится в Хайдарабаде, Индия.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

EBITDA 0.9997
EV/EBITDA 6.18
ISIN INE794A01010
Industry Pharmaceuticals
P/BV 0.5147
P/E 22.54
P/S 0.4822
Sector Health Care
Валюта inr
Валюта отчета inr
Выручка 7.58
Див.доход ао 0.36
Дивиденд ао 10
Сайт https://www.neulandlabs.com
Цена ао 12564.45
Число акций ао 0.01283 млрд
Change price per day: -1.44% (14428.2)
Change price per week: -6.84% (15265)
Change price per month: -4.49% (14889)
Change price per 3 month: +11.35% (12771.1)
Change price per half year: +112.1% (6704.85)
Change price per year: +177.99% (5115.5)
Change price per 3 year: +798.54% (1582.65)
Change price per 5 year: +2 718.49% (504.55)
Change price per year to date: +168.84% (5289.7)
All parameters

Underestimation

Title Value Grade
P/S 5.26 2
P/BV 6.39 1
P/E 27.3 6
EV/EBITDA 17.27 6
Total: 5.13

Efficiency

Title Value Grade
ROA, % 17.59 5
ROE, % 26.36 8
Total: 6.83

Dividends

Title Value Grade
Div yield, % 0.1296 0.33
DSI 0.9286 9.29
Total: 3.83

Debt

Title Value Grade
Debt/EBITDA 0.2009 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 105.69 10
Yield Ebitda, % 374.98 10
Yield EPS, % 1751.86 10
Total: 10
More

ETF Share, % Profitability for 1 year, % Dividends, %
Avantis Emerging Markets Equity ETF 0.02505 7.2411296162201 3.60513
Avantis Emerging Markets Value ETF 0.03932 14.118247818654 4.22231
Avantis Responsible Emerging Markets Equity ETF 0.09671 17.596669157681 3.1719
Dimensional World ex U.S. Core Equity 2 ETF 0.00561 13.062098501071 3.62488
Dimensional Emerging Markets Core Equity 2 ETF 0.03366 15.961857379768 3.34087
Dimensional Emerging Markets Value ETF 0.0128 17.066115702479 4.19508
iShares MSCI Emerging Markets Small-Cap ETF 0.10491 7.6741538179537 2.7853
WisdomTree India Earnings Fund 0.10482 13.063840276066 1.65591
SPDR S&P Emerging Markets Small Cap ETF 0.10859 5.7098342939481 3.03583
Matthews India Active ETF 3.39645 19.190841478136
iShares MSCI India Small-Cap ETF 0.28369 9.9479317327162 0.96163
SPDR Portfolio Emerging Markets ETF 0.00769 13.129858911604 3.1879
Vanguard ESG International Stock ETF 0 3.7566428440535 3.07501
Vanguard FTSE All-World ex-US Small-Cap ETF 0.04 9.3937465915288 3.09932



Head Job title Payment Year of birth
Dr. Davuluri Rama Mohan Rao Executive Chairman & Chief Promoter and Member of Scientific Advisory Board 60M 1944 (80 years)
Mr. Davuluri Sucheth Rao Vice Chairman & CEO 57.5M 1975 (49 years)
Mr. Davuluri Saharsh Rao Vice Chairman & MD 57.5M 1979 (45 years)
Mr. Abhijit Majumdar Chief Financial Officer N/A
Ms. Sarada Bhamidipati Company Secretary & Compliance Officer N/A
Mr. Y. Sudheer Senior Vice President of Global API Sales N/A 1963 (61 year)
Dr. Sharadsrikar Venkatesan Kotturi Chief Scientific Officer & Member of Scientific Advisory Board
Mr. Sudheer Yarabolu Senior VP of Global Head Sales & BD
Mr. Hemchandra Peruvelli Chief Human Resources Officer 1972 (52 years)
Mr. N. Sundar Chief Procurement Officer 1968 (56 years)

Address: India, Hyderabad, Phoenix IVY Building - open in Google maps, open in Yandex maps
Website: https://www.neulandlabs.com